These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2857632)
21. [Protein-losing enteropathy of cardiac origin: value of intestinal clearance of alpha-1-antitrypsin]. Prieto Bozano G; Ortega Páez E; Escribano Burgos C; Benito Bartolomé F; Herranz Macías A; Polanco Allúe I An Esp Pediatr; 1990 Jan; 32(1):73-5. PubMed ID: 2327669 [TBL] [Abstract][Full Text] [Related]
22. [Plasma clearance of alpha 1-antitrypsin. A simple method for the study of intestinal protein loss]. Olmos M; Villafañe V; Mazure P; Pizzolato M; Brizuela J Acta Gastroenterol Latinoam; 1985; 15(4):213-9. PubMed ID: 3879863 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease. Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis. Kapel N; Meillet D; Favennec L; Magne D; Raichvarg D; Gobert JG Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):197-202. PubMed ID: 1525248 [TBL] [Abstract][Full Text] [Related]
25. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces. van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220 [TBL] [Abstract][Full Text] [Related]
26. Random fecal alpha 1-antitrypsin excretion in children with intestinal disorders. Dinari G; Rosenbach Y; Zahavi I; Sivan Y; Nitzan M Am J Dis Child; 1984 Oct; 138(10):971-3. PubMed ID: 6332527 [TBL] [Abstract][Full Text] [Related]
28. Protein-losing gastroenteropathy detected by technetium-99m-labeled human serum albumin. Takeda H; Takahashi T; Ajitsu S; Ukai K; Saitoh H; Togashi H; Ishikawa M Am J Gastroenterol; 1991 Apr; 86(4):450-3. PubMed ID: 2012047 [TBL] [Abstract][Full Text] [Related]
29. Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Strygler B; Nicar MJ; Santangelo WC; Porter JL; Fordtran JS Gastroenterology; 1990 Nov; 99(5):1380-7. PubMed ID: 2210245 [TBL] [Abstract][Full Text] [Related]
30. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease]. López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651 [TBL] [Abstract][Full Text] [Related]
31. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Thomas DW; Sinatra FR; Merritt RJ Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702 [TBL] [Abstract][Full Text] [Related]
32. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea. Duarte MA; Carneiro SM; Melo MC; Penna FJ Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022 [TBL] [Abstract][Full Text] [Related]
33. Protein-losing enteropathy in systemic lupus erythematosus. Diagnosis and monitoring immunosuppressive therapy by alpha-1-antitrypsin clearance in stool. Benner KG; Montanaro A Dig Dis Sci; 1989 Jan; 34(1):132-5. PubMed ID: 2783407 [TBL] [Abstract][Full Text] [Related]
34. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion. López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686 [TBL] [Abstract][Full Text] [Related]
35. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
36. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411 [TBL] [Abstract][Full Text] [Related]
37. Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss. Quigley EM; Ross IN; Haeney MR; Holbrook IB; Marsh MN J Clin Pathol; 1987 Jan; 40(1):61-6. PubMed ID: 3493263 [TBL] [Abstract][Full Text] [Related]
38. Fecal alpha 1-antitrypsin in breast-fed infants is derived from human milk and is not indicative of enteric protein loss. Davidson LA; Lönnerdal B Acta Paediatr Scand; 1990 Feb; 79(2):137-41. PubMed ID: 2321474 [TBL] [Abstract][Full Text] [Related]
39. [Intestinal clearance of alpha 1-antitrypsin and exudative enteropathy]. Matuchansky C Gastroenterol Clin Biol; 1981 Feb; 5(2):183-6. PubMed ID: 6970698 [No Abstract] [Full Text] [Related]
40. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]